XML 54 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Disclosure About Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements of Assets, Liabilities and Noncontrolling Interests
The following table sets forth our assets and liabilities and the Company’s noncontrolling interests in the Operating Partnership that are measured or disclosed at fair value within the fair value hierarchy:

Level 1Level 2
TotalQuoted Prices
in Active
Markets for Identical Assets or Liabilities
Significant Observable Inputs
Fair Value as of December 31, 2022:
Assets:
Mortgages and notes receivable, at fair value (1)
$1,051 $— $1,051 
Marketable securities of non-qualified deferred compensation plan (in prepaid expenses and other assets)
2,564 2,564 — 
Total Assets$3,615 $2,564 $1,051 
Noncontrolling Interests in the Operating Partnership$65,977 $65,977 $— 
Liabilities:
Mortgages and notes payable, net, at fair value (1)
$2,832,973 $— $2,832,973 
Non-qualified deferred compensation obligation (in accounts payable, accrued expenses and other liabilities)
2,564 2,564 — 
Total Liabilities$2,835,537 $2,564 $2,832,973 
Fair Value as of December 31, 2021:
Assets:
Mortgages and notes receivable, at fair value (1)
$1,227 $— $1,227 
Marketable securities of non-qualified deferred compensation plan (in prepaid expenses and other assets)
2,866 2,866 — 
Total Assets$4,093 $2,866 $1,227 
Noncontrolling Interests in the Operating Partnership$111,689 $111,689 $— 
Liabilities:
Mortgages and notes payable, net, at fair value (1)
$2,907,492 $— $2,907,492 
Interest rate swaps (in accounts payable, accrued expenses and other liabilities)
60 — 60 
Non-qualified deferred compensation obligation (in accounts payable, accrued expenses and other liabilities)
2,866 2,866 — 
Total Liabilities$2,910,418 $2,866 $2,907,552 
__________
(1)    Amounts are not recorded at fair value on our Consolidated Balance Sheets as of December 31, 2022 and 2021.